Not Yet RecruitingNCT06228391
Ketamine versus midazolam for PTSD or depression after brain injury in veterans
About this title
Read the official source — NCT06228391Medication studyAges 18–75United States
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- MinneapolisSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: March 2024
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- Minneapolis Veterans Affairs Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT06228391
- Official title
Show the full official title
Examining the Efficacy and Safety of Subanesthetic Ketamine on Depression and Post-traumatic Stress Among Veterans With Mild and Moderate Traumatic Brain Injury
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Minneapolis Veterans Affairs Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including IV ketamine and Midazolam.
Who can participate?
Listed age limits: 18 years to 75 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
